Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 270-275

  Ho, Kean Fatt ^a   Farnell, Damien J J ^a   Routledge, Jacqueline A ^a   Burns, Meriel P ^a   Sykes, Andrew J ^b   Slevin, Nick J ^b   Davidson, Susan E ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

CTCAE; Head and neck radiotherapy; LENT SOMA; Patient reported outcomes; Quality of life; Radiotherapy late toxicity

Indexed keywords

ANALGESIC AGENT; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MOUTH EXAMINATION; NECK DISSECTION; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; STRUCTURED QUESTIONNAIRE; SWALLOWING; TOOTH PAIN; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; HEAD AND NECK NEOPLASMS; HEALTH STATUS INDICATORS; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RADIATION INJURIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 78149361726     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.01.017     Document Type: Article

References (29)

1. M.V. Williams The cancer reform strategy Clin Oncol (R Coll Radiol) 20 2008 271 274
2. S. Evans, J. Tritter, V. Barley, N. Daykin, J. McNeill, and N. Palmer User involvement in UK cancer services: bridging the policy gap Eur J Cancer Care (Engl) 12 2003 331 338
3. A. Trotti, and S.M. Bentzen The need for adverse effects reporting standards in oncology clinical trials J Clin Oncol 22 2004 19 22
4. K. Jensen, A. Bonde Jensen, and C. Grau The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires Radiother Oncol 78 2006 298 305
5. M. Palazzi, S. Tomatis, E. Orlandi, M. Guzzo, C. Sangalli, and P. Potepan Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system Int J Radiat Oncol Biol Phys 70 2008 330 337
6. S. Dische, M. Saunders, A. Barrett, A. Harvey, D. Gibson, and M. Parmar A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother Oncol 44 1997 123 136
7. M. Machtay, J. Moughan, A. Trotti, A.S. Garden, R.S. Weber, and J.S. Cooper Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis J Clin Oncol 26 2008 3582 3589
8. F.R. Burlage, J.M. Roesink, H.H. Kampinga, R.P. Coppes, C. Terhaard, and J.A. Langendijk Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study Int J Radiat Oncol Biol Phys 70 2008 14 22
9. A. Trotti, A.D. Colevas, A. Setser, and E. Basch Patient-reported outcomes and the evolution of adverse event reporting in oncology J Clin Oncol 25 2007 5121 5127
10. A. Meirovitz, C.A. Murdoch-Kinch, M. Schipper, C. Pan, and A. Eisbruch Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer Int J Radiat Oncol Biol Phys 66 2006 445 453
11. D.W. Bruner Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials? J Clin Oncol 25 2007 5345 5347
12. E. Basch, A. Iasonos, T. McDonough, A. Barz, A. Culkin, and M.G. Kris Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study Lancet Oncol 7 2006 903 909
13. D.I. Rosenthal, T.R. Mendoza, M.S. Chambers, J.A. Asper, I. Gning, and M.S. Kies Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module Head Neck 29 2007 923 931
14. LENT SOMA tables Radiother Oncol 35 1995 17 60
15. LENT SOMA scales for all anatomic sites Int J Radiat Oncol Biol Phys 31 1995 1049 1091
16. F. Denis, P. Garaud, E. Bardet, M. Alfonsi, C. Sire, and T. Germain Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems Int J Radiat Oncol Biol Phys 55 2003 93 98
17. S.E. Davidson, A. Trotti, O.U. Ataman, J. Seong, F.N. Lau, and N.W. da Motta Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency Int J Radiat Oncol Biol Phys 69 2007 1218 1221
18. K. Bjordal, E. Hammerlid, M. Ahlner-Elmqvist, A. de Graeff, M. Boysen, and J.F. Evensen Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35 J Clin Oncol 17 1999 1008 1019
19. K. Bjordal, A. de Graeff, P.M. Fayers, E. Hammerlid, C. van Pottelsberghe, and D. Curran A 12 country field study of the EORTC QLQ-C30 (version 30) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group Eur J Cancer 36 2000 1796 1807
20. N.K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, and N.J. Duez The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
21. J.A. Langendijk, P. Doornaert, I.M. Verdonck-de Leeuw, C.R. Leemans, N.K. Aaronson, and B.J. Slotman Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 26 2008 3770 3776
22. K. Ho, D. Farnell, J. Routledge, M. Burns, A. Sykes, N. Slevin, and S. Davidson Developing a CTCAE patient questionnaire for late toxicity after head and neck radiotherapy Eur J Cancer 45 2009 1992 1998
23. J.A. Routledge, M.P. Burns, R. Swindell, V.S. Khoo, C.M. West, and S.E. Davidson Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma Int J Radiat Oncol Biol Phys 56 2003 502 510
24. EORTC TEOfRaToC. EORTC QLQ-C30 scoring manual; 2001.
25. S.E. Davidson, M.P. Burns, J.A. Routledge, R. Swindell, S.M. Bentzen, and C.M. West Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary Radiother Oncol 69 2003 195 200
26. S.M. Bentzen, W. Dorr, M.S. Anscher, J.W. Denham, M. Hauer-Jensen, and L.B. Marks Normal tissue effects: reporting and analysis Semin Radiat Oncol 13 2003 189 202
27. R.V. Gowda, J.M. Henk, K.L. Mais, A.J. Sykes, R. Swindell, and N.J. Slevin Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience Radiother Oncol 68 2003 105 111
28. A. Snyers, G.O. Janssens, M.B. Twickler, A.R. Hermus, R.P. Takes, and A.C. Kappelle Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency Int J Radiat Oncol Biol Phys 2008
29. F. Wenz, G. Welzel, A. Keller, E. Blank, F. Vorodi, and C. Herskind Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer Breast 17 2008 617 622